COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02620046
Brief Title: Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

First Submitted : November 19, 2015
First Submitted that Met QC Criteria : November 30, 2015
First Posted : December 2, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : March 11, 2020
Last Update Posted : March 13, 2020